Patent application number | Description | Published |
20090024210 | MEDICATION DEPOT FOR MEDICAL IMPLANTS - A method for producing an agent depot for mechanical connection to a surface of an endovascular implantable body, comprising a) providing one or more polymers; b) providing one or more agents; and c) producing an agent depot from said polymers and said agents, the agent depot being mechanically connectable to the surface of the body using force action or adhesive. | 01-22-2009 |
20090030507 | DEGRADABLE METAL STENT HAVING AGENT-CONTAINING COATING - A stent comprising a degradable metal stent main body; a partition layer which is applied to the surface of the stent main body so that at least parts of the surface of the luminal side are not covered; and an agent-containing layer which is applied to the surface of the partition layer at least partially on the abluminal side of the stent main body and comprises one or more agents and possibly one or more polymers. | 01-29-2009 |
20090048524 | IMPLANTABLE PRESSURE MEASURING UNIT AND CONFIGURATION FOR INTERNAL PRESSURE MEASUREMENT IN A BLOOD VESSEL - Implantable pressure measuring unit for internal pressure measurement in a blood vessel or heart of a patient, having a pressure sensor having electrical signal output, fixing means adapted to the intended measurement location for fixing the pressure sensor, a power supply unit of the pressure sensor, a signal detection unit connected by a line to the signal output of the pressure sensor, and a transmitting unit connected to a measurement data output of the signal detection unit, in particular for wireless transmission of measurement data to an analysis unit, in particular outward from the patient body. | 02-19-2009 |
20090112307 | STENT HAVING A BASE BODY OF A BIOINERT METALLIC IMPLANT MATERIAL - A stent having a base body of a bioinert metallic implant material wherein the base body is covered with an SiC coating. An external surface of the base body has a plurality of cavities which are filled with an antiproliferative active ingredient, A luminal surface of the base body has a coating which contains or comprises attractors for endothelial cells. | 04-30-2009 |
20090148496 | IMPLANTS WITH MEMBRANE DIFFUSION-CONTROLLED RELEASE OF ACTIVE INGREDIENT - An implant for implantation in a human or animal body having a structure comprising a) an implant base body; b) a primer layer which is partially or completely applied to the surface of the implant; c) an active ingredient layer consisting of one, two, three or more active ingredients applied entirely or partially to the surface of the primer layer; and d) a diffusion-controlling layer which is applied partially or entirely to the active ingredient layer, and optionally to the primer layer, wherein diffusion of the active ingredients of the active ingredient layer is controlled. Also disclosed is a manufacturing method for an implant. | 06-11-2009 |
20090208555 | CONTROL OF THE DEGRADATION OF BIODEGRADABLE IMPLANTS USING A COATING - The invention relates to an endovascular implant, which is at least largely biodegradable and whose in vivo degradation can be controlled. To achieve this, the implant comprises a tubular base body, open on its end faces and consisting of at least one biodegradable material, said base body having an in vivo, location-dependent first degradation characteristic D | 08-20-2009 |
20090311304 | DRUG-LOADED IMPLANT - The invention relates to a drug-loaded implant having a carrier body ( | 12-17-2009 |
20090312721 | Implantable Drug Reservoir and Device Having an Implantable Drug Reservoir - The invention relates to an implantable drug reservoir ( | 12-17-2009 |
20100022894 | Intravascular Measurement - An implantable sensor for measuring fluidic parameters with a surface acoustic wave transponder for detecting vasomotor quantities and one retaining stent attached to each of two opposite ends of the surface acoustic wave transponder. | 01-28-2010 |
20100034899 | USE OF ONE OR MORE OF THE ELEMENTS FROM THE GROUP YTTRIUM, NEODYMIUM AND ZIRCONIUM, AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE ELEMENTS - A method of treating a patient includes the medical use of one or more of the elements from the group yttrium, neodymium and zirconium, pharmaceutical formulations which contain said elements and implants which are at least region-wise made up of such formulations. It has been found inter alia that a formulation containing one or more of the elements has an action of inhibiting the proliferation of human smooth muscle cells. | 02-11-2010 |
20100049300 | Stent and Method and Device for Fabricating the Stent - Stent, as well as a method and device for fabricating the stent, wherein the stent has a tubular lattice structure comprising individual struts and at least one strut of which at least one longitudinal section runs with at least one directional component in the radial circumferential direction of the stent, wherein the surface of the longitudinal section facing the outside of the stent is curved only about the longitudinal axis of the stent. According to the invention, the surface of longitudinal section of the strut, which surface faces the inside of the stent, has such a curvature that the strut cross section is fluidically optimized. | 02-25-2010 |
20100119576 | USE OF ONE OR MORE OF THE ELEMENTS FROM THE GROUP YTTRIUM, NEODYMIUM AND ZIRCONIUM, AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE ELEMENTS - A method of treating a patient includes the medical use of one or more of the elements from the group yttrium, neodymium and zirconium, pharmaceutical formulations which contain said elements and implants which are at least region-wise made up of such formulations. It has been found inter alia that a formulation containing one or more of the elements has an action of inhibiting the proliferation of human smooth muscle cells. | 05-13-2010 |
20110009952 | IMPLANT AND METHOD FOR MANUFACTURING SAME - The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. The following manufacturing method is provided for promotion of the anti-inflammatory effect of the implant: (i) providing the body of the implant; (ii) producing an at least partially closed pore structure in a portion of the structure of the implant body close to the surface; and (iii) incorporating NO | 01-13-2011 |
20110153005 | MEDICAL IMPLANT, COATING METHOD AND IMPLANTATION METHOD - One example of the invention relates to a medical implant having a base body comprising a first end and a second end, which are arranged at opposite ends of the base body in a main direction of the extent of the base body, and a coating, such that the coating has at least one active substance with an active substance gradient. It is proposed that the quantity of active substance shall decrease from the first end to the second end, at least in the main direction of extent of the base body. | 06-23-2011 |
20110178593 | MEDICATION DEPOT FOR MEDICAL IMPLANTS - An agent depot for mechanical connection to a surface of an endovascular implantable body, comprising one or more polymers, one or more bioactive agents, the agent depot being mechanically connectable to the implantable body by a force fit or an adhesive. | 07-21-2011 |
20120016466 | ABLUMINALLY COATED DRUG-ELUTING STENTS HAVING A FORM-FITTING PROTECTIVE LAYER - A drug-eluting stent, comprising a base body that is made of an implant material, the base body being partially or entirely covered on the abluminal side with an active ingredient-releasing coating that comprises or is made of a polymer and an active ingredient having an antiproliferative effect, characterized in that the stent's luminal surface and the abluminal surface carrying the active ingredient-releasing coating are covered by a biocorrodible protective layer in a form-fitting manner. | 01-19-2012 |
20120150284 | IMPLANT COMPRISING AN ACTIVE-AGENT-CONTAINING COATING COVERING THE IMPLANT AT LEAST IN SECTIONS - The invention relates to an implant comprising an active-agent-containing coating which covers the implant at least in sections. The coating is composed of at least two subsections; a first subsection contains the at least one active substance, and a second subsection contains an auxiliary agent. | 06-14-2012 |
20120191183 | MEDICAL VALVE IMPLANT, IN PARTICULAR HEART VALVE IMPLANT, FOR IMPLANTATION IN AN ANIMAL BODY AND/OR HUMAN BODY - The invention relates to a medical valve implant ( | 07-26-2012 |
20120203331 | IMPLANTATION DEVICE - The invention relates to an implantation device ( | 08-09-2012 |
20120214384 | Stent and Method and Device for Fabricating the Stent - Stent, as well as a method and device for fabricating the stent, wherein the stent has a tubular lattice structure comprising individual struts and at least one strut of which at least one longitudinal section runs with at least one directional component in the radial circumferential direction of the stent, wherein the surface of the longitudinal section facing the outside of the stent is curved only about the longitudinal axis of the stent. According to the invention, the surface of longitudinal section of the strut, which surface faces the inside of the stent, has such a curvature that the strut cross section is fluidically optimized. | 08-23-2012 |
20140030310 | IMPLANT AND METHOD FOR MANUFACTURING SAME - The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. The following manufacturing method is provided for promotion of the anti-inflammatory effect of the implant: (i) providing the body of the implant; (ii) producing an at least partially closed pore structure in a portion of the structure of the implant body close to the surface; and (iii) incorporating NO | 01-30-2014 |